CoTherix Ventavis Clears FDA For Pulmonary Arterial Hypertension
This article was originally published in The Pink Sheet Daily
Executive Summary
Launch is planned for the second quarter following export clearance from regulators in Spain, where iloprost is manufactured. The timing will also allow CoTherix to hire and train the Ventavis sales force prior to making product available.